N-(piperidine-4-yl)isobutylamide hydrochloride, 95.0%, 1g

(2S,4S)-1-(TERT-BUTOXYCARBONYL)-4-(METHOXYMETHYL)PYRROLIDINE-2-CARBOXYLIC ACID, 97.0%, 10g

4-Phenylbenzyl amine, 98.0%, 25g

1-(2-Chloro-phenyl)-1H-pyrrole-2-carbaldehyde, 1g

7-Methoxy-1H-indazole, 95.0%, 1g

n,2-Dihydroxy-5-methylbenzamide, 97%, 1g

(4-Cyclopropylphenyl)methanol, 5g

3-Methyl-2-(methylsulfonyl)butanoic acid, 95%, 1g

Ethyl isobutyrate, 99.0%, 100g

(2S,3S)-3-(tert-Butyl)-4-(2,6-dimethoxyphenyl)-2-isopropyl-2,3-dihydrobenzo[d][1,3]oxaphosphole, 97%, 1g

2-Bromo-N,N-diphenylacetamide, 98%, 1g

Trial kit Spectra/Por® Biotech CE, 8000–10000 dalton(s), 1 Piece(s)

4,6-Dibromopyrimidine, 96.0%, 1g